The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BTMD · Healthcare · Wide moat
On the watchlist
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | VRTX | REGN | A | BTMD |
|---|---|---|---|---|
| Moat Score (0–100) | 81 (highest) | 81 (highest) | 81 (highest) | 80 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 95 (highest) | 29 | 72 | 69 |
| Pricing power | 100 (highest) | 100 (highest) | 90 | — |
| Returns on capital | 96 | 97 | 84 | 100 (highest) |
| Balance-sheet safety | 73 | 100 (highest) | 71 | 73 |
| Capital allocation | 39 | 80 | 88 (highest) | 80 |
| 228% above value if growth stopped today | No price data | 174% above value if growth stopped today (largest discount to value if growth stopped today) | No price data | |
| Market cap | $121.2B | Not reported | $39.2B | Not reported |
| Moat tier | Wide moat | Wide moat | Wide moat | Wide moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |